‘Real-World’ Exenatide Efficacy Falls Short in Study

SAN FRANCISCO — The real-world efficacy of exenatide to lower hemoglobin A1c levels in patients with type 2 diabetes may not always match the success seen in clinical trials, a small retrospective study suggests.